PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,210 | -24.1% | 67,000 | -7.8% | 0.04% | -18.2% |
| Q2 2023 | $232,168 | +108.7% | 72,700 | +101.9% | 0.04% | +91.3% |
| Q1 2023 | $111,240 | -7.7% | 36,000 | +26.3% | 0.02% | +43.8% |
| Q4 2022 | $120,555 | +0.5% | 28,500 | -43.6% | 0.02% | -44.8% |
| Q3 2022 | $120,000 | -24.1% | 50,500 | -9.0% | 0.03% | -9.4% |
| Q2 2022 | $158,000 | -1.2% | 55,500 | 0.0% | 0.03% | +14.3% |
| Q1 2022 | $160,000 | -11.6% | 55,500 | -6.7% | 0.03% | -6.7% |
| Q4 2021 | $181,000 | – | 59,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |